Gritstone bio to Participate in Upcoming Investor Conferences
B.
Date and Time:
Presenter:
2023 BIO CEO & Investor Conference (Panel)
Panel Title: Prioritizing CRO Spending Through a High-Inflation, Sparse-Funding Period
Date and Time:
Presenter:
Date and Time:
Presenter:
Live webcast and/or archived replays will be available via https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for at least 30 days following the corresponding event.
About Gritstone bio
Gritstone is working to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors. Independently and with our partners, we are advancing a portfolio of product candidates with the aim of improving patient outcomes and eliminating disease. www.gritstonebio.com
Gritstone Contacts
Investors:
Director, Investor Relations & Corporate Communications
ir@gritstone.com
Media:
1AB
(973) 271-6085
dan@1abmedia.com
![](https://ml.globenewswire.com/media/ZmUyMDdjNjAtNjI2NC00YWRkLTlhMmUtNjVjZjAyYmI3OWUwLTExMzUwODU=/tiny/Gritstone-bio-Inc.png)